0001562180-21-002354.txt : 20210318 0001562180-21-002354.hdr.sgml : 20210318 20210318191703 ACCESSION NUMBER: 0001562180-21-002354 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210316 FILED AS OF DATE: 20210318 DATE AS OF CHANGE: 20210318 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Butler John P. CENTRAL INDEX KEY: 0001591467 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36352 FILM NUMBER: 21756012 MAIL ADDRESS: STREET 1: C/O RELYPSA, INC. STREET 2: 700 SAGINAW DR. CITY: REDWOOD CITY STATE: CA ZIP: 94063 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Akebia Therapeutics, Inc. CENTRAL INDEX KEY: 0001517022 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 208756903 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 245 FIRST STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-871-2098 MAIL ADDRESS: STREET 1: 245 FIRST STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2021-03-16 false 0001517022 Akebia Therapeutics, Inc. AKBA 0001591467 Butler John P. C/O AKEBIA THERAPEUTICS, INC. 245 FIRST STREET CAMBRIDGE MA 02142 true true false false CEO and President Common Stock 2021-03-16 4 A false 39520.00 0.00 A 1156262.00 D Common Stock 100000.00 I Held By Dorothy Butler GRAT November 2019 Common Stock 100000.00 I Held By John Butler GRAT November 2019 Common Stock 59928.00 I Held by Dorothy Butler 2019 GRAT Common Stock 59928.00 I Held by John Butler 2019 GRAT Common Stock 31047.00 I Held by Dorothy Butler Revocable Trust 2007 Common Stock 31047.00 I Held by John Butler Revocable Trust 2007 As previously disclosed, in February 2020, the Reporting Person was granted performance-based restricted stock unit awards ("PSUs") pursuant to the Issuer's 2014 Incentive Plan, as amended. The PSUs vest in connection with the achievement of specified commercial and regulatory milestones. On February 25, 2021, the Company reported its financial results for the year ended December 31, 2020. Subsequently, in accordance with the terms of the grant, the Issuer's Compensation Committee certified the achievement of a commercial milestone and, as a result, one third of the reported PSUs will vest on each of March 31, 2021, February 28, 2022 and February 28, 2023, subject to the Reporting Person's continued service with the Issuer on each vesting date. /s/ Andrea J. Paul, attorney-in-fact for John P. Butler 2021-03-18